Outcome of childhood acute Lymphoblastic leukemia in Egyptian children: A challenge for limited health resource countries

References

• Pui CH, Cheng C, Leung W, Rai SN, Rivera GK, Sandlund JT, et al. Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N Engl J Med. 2003;349(7):640–9.
   PubMed Web of Science ®Google Scholar
• Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;25:360(26):2730–41.
   Web of Science ®Google Scholar
• Schrappe M, Camitta B, Pui CH, Eden T, Gaynon P, Gustafsson G, et al. Long-term results of large prospective trials in childhood acute lymphoblastic leukemia. Leukemia. 2000;14(12):2193–4.
   PubMed Web of Science ®Google Scholar
• Kulkarni KP, Arora RS, Marwaha RK. Survival outcome of childhood acute lymphoblastic leukemia in India: a resource-limited perspective of more than 40 years. J Pediatr Hematol Oncol. 2011;33(6):475–9.
   PubMed Web of Science ®Google Scholar
• Phan VH, Moore MM, McLachlan AJ, Piquette-Miller M, Xu H, Clarke SJ. Ethnicdifferences in drug metabolism and toxicity from chemotherapy. Expert Opin Drug Metab Toxicol. 2009;5(3):243–57.
   PubMed Web of Science ®Google Scholar
• Matloub Y, Angiolillo A, Bostrom B, Hunger SP, Stork LC, Angiolillo A, Sather H, et al. Double delayed intensification (DDI) is equivalent to single DI (SDI) in children with National Cancer Institute (NCI) standard-risk acute lymphoblastic leukemia (SR-ALL) treated on Children's Cancer Group (CCG) clinical trial 1991 (CCG-1991). Blood. 2006;108(11):A-146.
   Web of Science ®Google Scholar
• Seibel NL, Steinherz PG, Sather HN, Nachman JB, Delaat C, Ettinger LJ, et al. Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood. 2008;1:111(5):2548–55.
   PubMed Web of Science ®Google Scholar
• Gaynon PS, Trigg ME, Heerema NA, Sensel MG, Sather HN, Hammond GD, et al. Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995. Leukemia. 2000;14(12):2223–33.
   PubMed Web of Science ®Google Scholar
• Gaynon PS, Angiolillo AL, Carroll WL, Nachman JB, Trigg ME, Sather HN, et al. Children's Oncology Group.Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983–2002: a Children's Oncology Group Report. Leukemia. 2010;24(2):285–97.
   PubMed Web of Science ®Google Scholar
• Halalsheh H, Abuirmeileh N, Rihani R, Bazzeh F, Zaru L, Madanat F. Outcome of childhood acute lymphoblastic leukemia in Jordan. Pediatr Blood Cancer. 2011;57(3):385–91.
   PubMed Web of Science ®Google Scholar
• Hutchinson RJ, Gaynon PS, Sather H, Bertolone SJ, Cooper HA, Tannous R, et al., Children's Cancer Group/Children's Oncology Group. Intensification of therapy for children with lower-risk acute lymphoblastic leukemia: long-term follow-up of patients treated on Children's Cancer Group Trial 1881. J Clin Oncol. 2003;1;21(9):1790–7.
   PubMed Web of Science ®Google Scholar
• Bostrom BC, Sensel MR, Sather HN, Gaynon PS, La MK, Johnston K, et al. Children's Cancer Group. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood. 2003;15;101(10):3809–17.
   Web of Science ®Google Scholar
• Bleyer WA, Sather HN, Nickerson HJ, Coccia PF, Finklestein JZ, Miller DR, et al. Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Children's Cancer Study Group. J Clin Oncol. 1991;9:1012–21.
   PubMed Web of Science ®Google Scholar
• Eden TO, Pieters R, Richards S. Childhood Acute Lymphoblastic Leukaemia Collaborative Group (CALLCG). Systematic review of the addition of vincristine plus steroid pulses in maintenance treatment for childhood acute lymphoblastic leukaemia – an individual patient data meta-analysis involving 5,659 children. Br J Haematol. 2010;149(5):722–33.
   PubMed Web of Science ®Google Scholar
• Nachman JB, La MK, Hunger SP, Heerema NA, Gaynon PS, Hastings C, et al. Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group. J Clin Oncol. 2009;1;27(31):5189–94.
   PubMed Web of Science ®Google Scholar
• Gaynon PS, Desai AA, Bostrom BC, Hutchinson RJ, Lange BJ, Nachman JB, et al. Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review. Cancer. 1997;1;80(9):1717–26.
   PubMed Web of Science ®Google Scholar
• van Dongen JJ, Seriu T, Panzer-Grumayer ER, Biondi A, Pongers-Willemse MJ, Corral L, et al. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet. 1998;352:1731–8.
   PubMed Web of Science ®Google Scholar
• Cave H, van der Werff ten Bosch J, Suciu S, Guidal C, Waterkeyn C, Otten J, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer – Childhood Leukemia Cooperative Group. New Engl J Med. 1998;339:591–8.
   PubMed Web of Science ®Google Scholar
• Lange BJ, Bostrom BC, Cherlow JM, Sensel MG, La MK, Rackoff W, et al. Children's Cancer Group. Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood. 2002;1;99(3):825–33.
   PubMed Web of Science ®Google Scholar
• Arya LS, Padmanjali KS, Sazawal S, Saxena R, Bhargava M, Kulkarni KP, et al. Childhood T-lineage acute lymphoblastic leukemia: management and outcome at a tertiary care center in North India. Indian Pediatr. 2011;48(10):785–90.
   PubMed Web of Science ®Google Scholar